Lung Cancer News at Annual Meeting 2016: Continued Focus on Immunotherapy

What is the latest news on lung cancer immunotherapies? On location at ASCO 2016, lung cancer expert Dr. Charu Aggarwal of the University of Pennsylvania Hospital gives an update. Dr. Aggarwal gives a brief glimpse at the results of combination immunotherapy data, including crizotinib (Xalkori) and alectinib (Alecensa).

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo